![Dora Ferrari](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Dora Ferrari
Corporate Officer/Principal chez CURIS, INC.
Profil
Dora Ferrari is currently the Vice President-Clinical Operations at Curis, Inc. Prior to this, she worked as the Director-Clinical Development & Program Management at ArQule, Inc., a Clinical Research Associate at EPIX Pharmaceuticals, Inc., and the VP-Clinical Development & Program Management at Aileron Therapeutics, Inc. She completed her undergraduate degree at the University of Massachusetts.
Postes actifs de Dora Ferrari
Sociétés | Poste | Début |
---|---|---|
CURIS, INC. | Corporate Officer/Principal | 03/01/2021 |
Anciens postes connus de Dora Ferrari
Sociétés | Poste | Fin |
---|---|---|
ARQULE, INC. | Corporate Officer/Principal | - |
EPIX Pharmaceuticals, Inc.
![]() EPIX Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology EPIX Pharmaceuticals, Inc. used to develop targeted contrast agents both to improve the capability and expand the use of magnetic resonance imaging (MRI) as a tool for diagnosing human disease. The company was founded in 1988 and was headquartered in Lexington, MA. | Corporate Officer/Principal | - |
AILERON THERAPEUTICS, INC. | Directeur Technique/Scientifique/R&D | - |
Formation de Dora Ferrari
University of Massachusetts | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 2 |
---|---|
AILERON THERAPEUTICS, INC. | Health Technology |
CURIS, INC. | Health Technology |
Entreprise privées | 2 |
---|---|
ArQule, Inc.
![]() ArQule, Inc. Pharmaceuticals: MajorHealth Technology ArQule, Inc. is a biopharmaceutical company, which engages in the research and development of therapeutics to treat cancers and rare diseases. The company was founded in 1993 and is headquartered in Burlington, MA. | Health Technology |
EPIX Pharmaceuticals, Inc.
![]() EPIX Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology EPIX Pharmaceuticals, Inc. used to develop targeted contrast agents both to improve the capability and expand the use of magnetic resonance imaging (MRI) as a tool for diagnosing human disease. The company was founded in 1988 and was headquartered in Lexington, MA. | Health Technology |